Biotron's Phase 2 Trial Confirms BIT225 HIV Treatment Potential

Small CapsJun 18 22:03 ET

Biotron Meets Primary Objectives of Phase Two HIV Trial; Shares Surge 25%

MT NewswiresApr 4 21:35 ET

Stocks of the Hour: Linius Technologies, Biotron, Elixir Energy

sharecafeApr 4 20:43 ET

Biotron Secures Nearly AU$2 Million R&D Tax Rebate in Fiscal 2023

MT NewswiresFeb 8 00:46 ET

Biotron Completes Dosing Segment of Phase Two COVID-19 Clinical Trial

MT NewswiresAug 16, 2023 03:55 ET

Biotron (ASX:BIT) Kicks off Phase II COVID-19 Clinical Trial in Thailand

The Market HeraldMay 3, 2023 22:37 ET